Truist Financial Corp Acquires 4,229 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Truist Financial Corp lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) by 14.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 33,441 shares of the medical instruments supplier’s stock after acquiring an additional 4,229 shares during the quarter. Truist Financial Corp’s holdings in DENTSPLY SIRONA were worth $947,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in XRAY. Nuance Investments LLC grew its stake in shares of DENTSPLY SIRONA by 356.3% during the 2nd quarter. Nuance Investments LLC now owns 9,051,338 shares of the medical instruments supplier’s stock worth $323,404,000 after acquiring an additional 7,067,751 shares during the period. Wellington Management Group LLP grew its stake in shares of DENTSPLY SIRONA by 83.1% during the 1st quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock worth $270,829,000 after acquiring an additional 2,497,773 shares during the period. Lazard Asset Management LLC grew its stake in shares of DENTSPLY SIRONA by 11,805,127.3% during the 2nd quarter. Lazard Asset Management LLC now owns 1,298,575 shares of the medical instruments supplier’s stock worth $46,397,000 after acquiring an additional 1,298,564 shares during the period. Artisan Partners Limited Partnership grew its stake in shares of DENTSPLY SIRONA by 9.3% during the 2nd quarter. Artisan Partners Limited Partnership now owns 12,758,726 shares of the medical instruments supplier’s stock worth $455,869,000 after acquiring an additional 1,089,244 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of DENTSPLY SIRONA by 10.0% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 9,987,997 shares of the medical instruments supplier’s stock worth $356,871,000 after acquiring an additional 905,001 shares during the period. Institutional investors own 98.52% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $36.97 on Friday. The stock has a market cap of $7.95 billion, a price-to-earnings ratio of 13.69, a P/E/G ratio of 4.97 and a beta of 0.87. The company has a current ratio of 1.50, a quick ratio of 1.04 and a debt-to-equity ratio of 0.48. DENTSPLY SIRONA Inc. has a 1-year low of $26.48 and a 1-year high of $58.70. The stock’s 50-day moving average is $32.15 and its 200 day moving average is $32.42.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last announced its quarterly earnings data on Monday, November 14th. The medical instruments supplier reported $0.41 earnings per share for the quarter, missing analysts’ consensus estimates of $0.59 by ($0.18). The firm had revenue of $947.00 million for the quarter, compared to analysts’ expectations of $1.01 billion. DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The business’s quarterly revenue was down 8.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.68 earnings per share. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.96 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 13th. Investors of record on Friday, December 30th were given a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, December 29th. This represents a $0.50 annualized dividend and a yield of 1.35%.

Analysts Set New Price Targets

Several brokerages have commented on XRAY. William Blair upgraded DENTSPLY SIRONA from an “underperform” rating to a “market perform” rating in a research note on Wednesday, January 11th. Robert W. Baird cut their target price on DENTSPLY SIRONA to $32.00 in a research note on Thursday, November 17th. UBS Group cut their target price on DENTSPLY SIRONA to $35.00 in a research note on Thursday, November 17th. TheStreet downgraded DENTSPLY SIRONA from a “c” rating to a “d” rating in a research note on Monday, November 14th. Finally, Evercore ISI raised their price target on DENTSPLY SIRONA to $34.00 in a report on Thursday, November 17th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average price target of $40.70.

DENTSPLY SIRONA Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Recommended Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.